End-of-day quote
Taipei Exchange
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
35.25
TWD
|
-0.56%
|
|
-0.14%
|
-25.71%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,990
|
3,732
|
2,576
|
5,880
|
4,634
|
3,938
|
Enterprise Value (EV)
1 |
4,051
|
3,694
|
2,513
|
6,046
|
4,653
|
3,751
|
P/E ratio
|
-3.6
x
|
-7.39
x
|
-3.4
x
|
-10.5
x
|
-11
x
|
-6.78
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
26.5
x
|
9.62
x
|
18.1
x
|
18.8
x
|
6.55
x
|
4.86
x
|
EV / Revenue
|
26.9
x
|
9.52
x
|
17.6
x
|
19.3
x
|
6.58
x
|
4.63
x
|
EV / EBITDA
|
-8.83
x
|
-20.4
x
|
-4.47
x
|
-24.9
x
|
-15.5
x
|
-9.79
x
|
EV / FCF
|
-29.1
x
|
-19.9
x
|
-7.79
x
|
-30.2
x
|
-15.8
x
|
-24.9
x
|
FCF Yield
|
-3.44%
|
-5.03%
|
-12.8%
|
-3.31%
|
-6.31%
|
-4.02%
|
Price to Book
|
2.67
x
|
2.71
x
|
2.46
x
|
11.8
x
|
6.49
x
|
5.21
x
|
Nbr of stocks (in thousands)
|
42,495
|
48,752
|
60,000
|
60,000
|
70,000
|
83,000
|
Reference price
2 |
93.90
|
76.56
|
42.94
|
98.00
|
66.20
|
47.45
|
Announcement Date
|
3/27/19
|
3/31/20
|
3/12/21
|
3/30/22
|
3/28/23
|
3/21/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
150.7
|
388.1
|
142.7
|
312.9
|
707.5
|
810.3
|
EBITDA
1 |
-458.9
|
-180.8
|
-562.3
|
-242.5
|
-300.6
|
-383.1
|
EBIT
1 |
-591.5
|
-268.3
|
-652.8
|
-318.5
|
-379.7
|
-447.1
|
Operating Margin
|
-392.5%
|
-69.13%
|
-457.41%
|
-101.79%
|
-53.67%
|
-55.17%
|
Earnings before Tax (EBT)
1 |
-1,110
|
-467.8
|
-679.2
|
-558.7
|
-398.1
|
-467.4
|
Net income
1 |
-1,107
|
-467.8
|
-679.2
|
-558.7
|
-398.1
|
-519.4
|
Net margin
|
-734.93%
|
-120.53%
|
-475.94%
|
-178.57%
|
-56.27%
|
-64.09%
|
EPS
2 |
-26.06
|
-10.36
|
-12.62
|
-9.311
|
-5.997
|
-7.003
|
Free Cash Flow
1 |
-139.3
|
-185.8
|
-322.6
|
-199.9
|
-293.8
|
-150.9
|
FCF margin
|
-92.41%
|
-47.89%
|
-226.09%
|
-63.91%
|
-41.53%
|
-18.63%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/27/19
|
3/31/20
|
3/12/21
|
3/30/22
|
3/28/23
|
3/21/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
60.6
|
-
|
-
|
166
|
19.4
|
-
|
Net Cash position
1 |
-
|
38.1
|
63.3
|
-
|
-
|
187
|
Leverage (Debt/EBITDA)
|
-0.132
x
|
-
|
-
|
-0.6842
x
|
-0.0644
x
|
-
|
Free Cash Flow
1 |
-139
|
-186
|
-323
|
-200
|
-294
|
-151
|
ROE (net income / shareholders' equity)
|
-48.9%
|
-32.6%
|
-56.1%
|
-72.5%
|
-65.8%
|
-70.7%
|
ROA (Net income/ Total Assets)
|
-13.6%
|
-8.41%
|
-24.7%
|
-15.9%
|
-19.8%
|
-21.4%
|
Assets
1 |
8,123
|
5,562
|
2,746
|
3,524
|
2,009
|
2,430
|
Book Value Per Share
2 |
35.20
|
28.20
|
17.40
|
8.280
|
10.20
|
9.110
|
Cash Flow per Share
2 |
8.230
|
6.530
|
5.300
|
3.620
|
3.360
|
4.620
|
Capex
1 |
57.1
|
149
|
73.3
|
26.3
|
83.2
|
53.3
|
Capex / Sales
|
37.86%
|
38.38%
|
51.4%
|
8.42%
|
11.76%
|
6.58%
|
Announcement Date
|
3/27/19
|
3/31/20
|
3/12/21
|
3/30/22
|
3/28/23
|
3/21/24
|
|
1st Jan change
|
Capi.
|
---|
| -25.71% | 89.69M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|